GOLDEN BIOTECHNOLOGY CROP

Company Introduction: Golden Biotechnology Corporation

It is a factory (manufacturer) with strong research and development capabilities.

Golden Biotechnology Corporation (GBC) is a leading biopharmaceutical company based in Taiwan. The company is primarily engaged in the research, development, manufacturing, and commercialization of innovative new drugs and health supplements. GBC leverages its proprietary biotechnology platforms, particularly focusing on the development of products derived from Antrodia cinnamomea (Antrodia camphorata), for various therapeutic areas including oncology, liver diseases, kidney diseases, and autoimmune diseases. With a strong emphasis on scientific research and clinical trials, GBC operates its own manufacturing facilities to produce its patented compounds and formulations, positioning itself as a vertically integrated biopharmaceutical enterprise rather than solely a trading company.

Golden Biotechnology Corp (GBC) focuses on the research and development of new drugs and health supplements. Below are the primary products they produce and market:

Core Pharmaceutical Products

Antroquinonol (Hocena): A novel small-molecule drug currently in various stages of clinical trials for indications including non-small cell lung cancer (NSCLC), pancreatic cancer, and potential applications for COVID-19 and other inflammatory diseases.

Health Supplement Products

Antromax: A branded ingredient derived from Antrodia cinnamomea, a rare mushroom native to Taiwan. It is marketed for its potential in liver protection, immune system support, and fatigue reduction.

Synergistic Health Series: A range of dietary supplements developed using their proprietary fermentation technology, often focusing on metabolic health, liver function support, and general wellness.

Research and Development Focus

The company primarily operates as a biopharmaceutical firm, meaning their product pipeline is heavily weighted toward clinical-stage drug candidates derived from their proprietary platform technology rather than a vast catalog of consumer retail goods.